Update on the pathologic diagnosis of chronic myelomonocytic leukemia

被引：17
|
作者：
Arber, Daniel A. [1 ]
Orazi, Attilio [2 ]
机构：
[1] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA
[2] Texas Tech Hlth Sci Ctr, Dept Pathol, El Paso, TX USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷 / 06期
关键词：
AGE-RELATED MUTATIONS; PRIMARY MYELOFIBROSIS; CLONAL HEMATOPOIESIS; RISK STRATIFICATION; MYELOID NEOPLASMS; MONOCYTOSIS; SURVIVAL; FEATURES; CLASSIFICATION; ACCUMULATION;
D O I：
10.1038/s41379-019-0215-y
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The diagnostic criteria for chronic myelomonocytic leukemia were recently revised in the 2016 World Health Organization classification update and include new and revised subtypes. In addition, molecular genetic studies have provided new insights into the prognosis and diagnosis of this myeloid neoplasm. This review summarizes the 2016 changes to the diagnostic criteria, discusses potential future changes that may impact diagnosis and provides an overview of recent advances in the diagnosis and prognosis determination of chronic myelomonocytic leukemia.
引用
收藏
页码：732 / 740
页数：9
相关论文
共 50 条
  • [1] How I investigate chronic myelomonocytic leukemia
    Sangiorgio, Valentina Fabiola Ilenia
    Arber, Daniel A.
    Orazi, Attilio
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (02) : 101 - 108
  • [2] Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (01) : 97 - 115
  • [3] Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) : 824 - 840
  • [4] Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) : 632 - 642
  • [5] Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (06) : 1142 - 1165
  • [6] Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : 352 - 372
  • [7] Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia
    Lackner, David
    Geissler, Klaus
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 27 - 33
  • [8] Recent Updates on Chronic Myelomonocytic Leukemia
    Loghavi, Sanam
    Khoury, Joseph D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 446 - 454
  • [9] Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
    Geyer, Julia T.
    Tam, Wayne
    Liu, Yen-Chun
    Chen, Zhengming
    Wang, Sa A.
    Bueso-Ramos, Carlos
    Oak, Jean
    Arber, Daniel A.
    Hsi, Eric
    Rogers, Heesun J.
    Levinson, Katherine
    Bagg, Adam
    Hassane, Duane C.
    Hasserjian, Robert P.
    Orazi, Attilio
    MODERN PATHOLOGY, 2017, 30 (09) : 1213 - 1222
  • [10] Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia
    Zack, Marie-Therese
    Geissler, Klaus
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 21 - 26
12345